Purulent Anthritis of Knee joint
purulent septic arthritis knee joint etiology diagnosis management
purulent septic arthritis knee joint
| Route | Description |
|---|---|
| Hematogenous (most common) | Bacteremia seeds the highly vascular synovium |
| Direct inoculation | Trauma, surgery, intra-articular injection |
| Contiguous spread | Adjacent osteomyelitis or soft tissue infection |
| Population | Organisms |
|---|---|
| Adults (non-STI) | Staphylococcus aureus (most common overall), Streptococcus spp., Gram-negatives |
| Sexually active adults | Neisseria gonorrhoeae (most common in young adults) |
| Elderly / immunocompromised | S. aureus, Gram-negatives (E. coli, Pseudomonas) |
| Children (< 5 yrs) | Kingella kingae, S. aureus, Group B Strep |
| IV drug users | Pseudomonas aeruginosa, S. aureus |
| Prosthetic joint | S. epidermidis, S. aureus, Cutibacterium acnes |

| Test | Finding in Septic Arthritis |
|---|---|
| WBC | Elevated (non-specific) |
| ESR / CRP | Elevated (non-specific) |
| Blood cultures | Positive in ~50% — collect during febrile episodes |
| Procalcitonin | May support bacterial infection |
| Parameter | Normal | Septic Arthritis |
|---|---|---|
| Appearance | Clear, straw-colored | Turbid, yellow-green, purulent |
| Viscosity | High | Low |
| WBC (cells/mm³) | < 200 | > 50,000 (often > 100,000); predominantly PMNs > 75% |
| Glucose | Equal to serum | Reduced |
| Protein | Low | Elevated |
| Gram stain | Negative | Positive in 50–70% |
| Culture | Negative | Positive in 70–90% (send in blood culture bottles) |
Per the Guide to Utilization of the Microbiology Laboratory (p. 82): "Traditionally, a synovial fluid leukocyte count more than 50,000 cells/mm³ was considered to suggest septic arthritis; however, lower counts do not exclude the diagnosis." If Gram stain and culture are negative, multiplex PCR or 16S rRNA gene PCR/sequencing should be considered. K. kingae and N. gonorrhoeae are included in recently FDA-cleared multiplex PCR panels for synovial fluid.
| Modality | Findings |
|---|---|
| X-ray | Early: soft tissue swelling, joint space widening; Late: osteopenia, joint space narrowing, bony destruction |
| Ultrasound | Joint effusion (guides aspiration), synovial thickening |
| MRI (most sensitive) | Effusion, synovial enhancement, bone marrow edema, cartilage destruction, adjacent soft tissue involvement |
| Method | Indication |
|---|---|
| Serial needle arthrocentesis | Early, accessible effusions; initial management |
| Arthroscopic lavage & debridement | Preferred when feasible; allows direct visualization |
| Open surgical drainage | Failed arthroscopy, loculated collections, adjacent osteomyelitis, prosthetic joint infection |
| Clinical Scenario | Empiric Regimen |
|---|---|
| Healthy adult (non-STI) | Flucloxacillin or Nafcillin (anti-staphylococcal) IV |
| MRSA risk or penicillin allergy | Vancomycin IV |
| Gram-negative concern (elderly, immunocompromised, IVDU) | Add 3rd-gen cephalosporin or Piperacillin-tazobactam |
| Gonococcal arthritis | Ceftriaxone 1g IV/IM daily |
| Children | Flucloxacillin ± cefotaxime (cover K. kingae) |
| Complication | Details |
|---|---|
| Cartilage destruction | From proteolytic enzymes; begins within hours–days |
| Osteomyelitis | Contiguous spread to bone |
| Avascular necrosis | Especially femoral head if hip involved |
| Joint fibrosis / ankylosis | Chronic stiffness, loss of function |
| Chronic osteomyelitis | In inadequately treated cases |
| Septicemia / sepsis | Life-threatening systemic spread |
| Growth disturbance | In children (epiphyseal involvement) |
Key Clinical Pearl: The combination of acute monoarthritis + fever + purulent joint fluid must be treated as septic arthritis until proven otherwise. Do not delay arthrocentesis and empiric antibiotics waiting for imaging or confirmatory cultures.